Table 3

Summary of AJCC (8th Edition) TNM staging for CSCC* (adapted from Cañueto and Román-Curto176)

StagePrimary tumor (T)Lymph node (N)Metastasis (M)
0In situ primary tumorNo lymph node metastasis (clinical or pathological exam)No distant metastasis
ITumor ≤2 cm acrossNo lymph node metastasis (clinical or pathological exam)No distant metastasis
IITumor >2 cm but ≤4 cm acrossNo lymph node metastasis (clinical or pathological exam)No distant metastasis
IIITumor ≤2 cm acrossMetastasis in an isolated ipsilateral lymph node ≤3 cm, no ENE†
(clinical or pathological exam)
No distant metastasis
Tumor >2 cm but ≤4 cm acrossMetastasis in an isolated ipsilateral lymph node ≤3 cm, no ENE†
(clinical or pathological exam)
No distant metastasis
Tumor >4 cm across, minor bone invasion, perineural invasion, or deep invasion‡No lymph node metastasis (clinical or pathological exam)No distant metastasis
Tumor >4 cm across, minor bone invasion, perineural invasion, or deep invasion‡Metastasis in an isolated ipsilateral lymph node ≤3 cm, no ENE†
(clinical or pathological exam)
No distant metastasis
IVTumor ≤2 cm acrossClinical exam:
Metastasis in an isolated ipsilateral lymph node >3 to ≤6 cm, no ENE†
Metastasis in multiple ipsilateral lymph nodes ≤6 cm, no ENE†
Metastasis in bilateral or contralateral lymph nodes ≤6 cm, no ENE†
No distant metastasis
Pathological exam:
Metastasis in an isolated ipsilateral lymph node ≤3 cm, ENE-positive†
Metastasis in an isolated ipsilateral lymph node >3 cm to ≤6 cm; No ENE†
Metastasis in multiple ipsilateral lymph nodes ≤6 cm, no ENE†
Metastasis in bilateral or contralateral lymph nodes ≤6 cm, no ENE†
Tumor >2 cm but ≤4 cm acrossClinical exam:
Metastasis in an isolated ipsilateral lymph node >3 to ≤6 cm, no ENE†
Metastasis in multiple ipsilateral lymph nodes ≤6 cm; No ENE†
Metastasis in bilateral or contralateral lymph nodes ≤6 cm; No ENE†
No distant metastasis
Pathological exam:
Metastasis in an isolated ipsilateral lymph node ≤3 cm; ENE-positive†
Metastasis in an isolated ipsilateral lymph node >3 cm to ≤6 cm, no ENE†
Metastasis in multiple ipsilateral lymph nodes ≤6 cm, no ENE†
Metastasis in bilateral or contralateral lymph nodes ≤6 cm, no ENE†
Tumor >4 cm across, minor bone invasion, perineural invasion, or deep invasion‡Clinical exam:
Metastasis in an isolated ipsilateral lymph node >3 to ≤6 cm, no ENE†
Metastasis in multiple ipsilateral lymph nodes ≤6 cm, no ENE†
Metastasis in bilateral or contralateral lymph nodes ≤6 cm, no ENE†
No distant metastasis
Pathological exam:
Metastasis in an isolated ipsilateral lymph node ≤3 cm, ENE-positive†
Metastasis in an isolated ipsilateral lymph node >3 cm to ≤6 cm, no ENE†
Metastasis in multiple ipsilateral lymph nodes ≤6 cm, no ENE†
Metastasis in bilateral or contralateral lymph nodes ≤6 cm, no ENE†
Tumor with gross cortical bone and/or marrow invasion, skull base invasion and/or skull base foramen invasionNearby lymph node(s) may or may not be positive (clinical or pathological)No distant metastasis
Any tumor size or depthClinical exam:
Metastasis in a lymph node >6 cm, no ENE†
Metastasis in any lymph node(s) and ENE-positive† (clinically overt)
No distant metastasis
Pathological exam:
Metastasis in a lymph node >6 cm, no ENE†
Metastasis in an isolated ipsilateral lymph node >3 cm, ENE-positive†
Metastasis in multiple ipsilateral, contralateral or bilateral lymph nodes; any with ENE-positive†
Metastasis in a single contralateral lymph nodes (any size), ENE-positive†
Any tumor size or depthNearby lymph node may or may not be positive (clinical or pathological)Distant metastasis
  • *The AJCC 8th Edition staging table was developed for CSCC of the head and neck.

  • †ENE is defined as extension through the lymph node capsule in the surrounding connective tissue with or without stromal reaction.

  • ‡Deep invasion is defined as invasion beyond the subcutaenous fat or >6 mm (measured from the granular layer of adjacent normal epidermis to the base of the tumor); perineural invasion is defined as tumor cells in the nerve sheath of a nerve lying deeper than the dermis or measuring ≥0.1 mm in caliber or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression.

  • AJCC, American Joint Committee on Cancer; CSCC, cutaneous squamous cell carcinoma; ENE, extranodal or extracapsular nodal extension; M, metastasis; N, lymph node; T, primary tumor; TNM, tumor, node, metastasis.